相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression
Nosratola D. Vaziri et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Lipid Disorders and Their Relevance to Outcomes in Chronic Kidney Disease
Nosratola D. Vaziri et al.
BLOOD PURIFICATION (2011)
Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease
Esther M. M. Ooi et al.
JOURNAL OF LIPID RESEARCH (2011)
New Insights Into Lipid Metabolism in Chronic Kidney Disease
George A. Kaysen
JOURNAL OF RENAL NUTRITION (2011)
ApoA-1 Mimetic Peptide Reverses Uremia-Induced Upregulation of Pro-Atherogenic Pathways in the Aorta
Nosratola D. Vaziri et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Niacin improves renal lipid metabolism and slows progression in chronic kidney disease
Kyu-hyang Cho et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2010)
HDL metabolism and activity in chronic kidney disease
Nosratola D. Vaziri et al.
NATURE REVIEWS NEPHROLOGY (2010)
Reverse Cholesterol Transport Pathway in Experimental Chronic Renal Failure
Hamid Moradi et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Sterol Regulatory Element-Binding Proteins, Liver X Receptor, ABCA1 Transporter, CD36, Scavenger Receptors A1 and B1 in Nephrotic Kidney
Hyun Ju Kim et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide
Nosratola D. Vaziri et al.
KIDNEY INTERNATIONAL (2009)
Lipoprotein Lipase Disturbances Induced by Uremia and Hemodialysis
Bernd Stegmayr et al.
SEMINARS IN DIALYSIS (2009)
Causes of Dysregulation of Lipid Metabolism in Chronic Renal Failure
Nosratola D. Vaziri
SEMINARS IN DIALYSIS (2009)
Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease
Hamid Moradi et al.
TRANSLATIONAL RESEARCH (2009)
Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney
Hyun Ju Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
The effect of lipoproteins on the development and progression of renal disease
Lorien S. Dalrymple et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Safety considerations with fibrate therapy
Michael H. Davidson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Lipoprotein metabolism and lipid management in chronic kidney disease
Bonnie C. H. Kwan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the veterans affairs high-density lipoprotein intervention trial
JD Otvos et al.
CIRCULATION (2006)
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
ND Vaziri
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Down-regulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure
C Kim et al.
KIDNEY INTERNATIONAL (2005)
Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure
ND Vaziri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription
S Ishii et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cellular lipid metabolism and the role of lipids in progressive renal disease
CK Abrass
AMERICAN JOURNAL OF NEPHROLOGY (2004)
Dialysis modalities and dyslipidemia
PO Attman et al.
KIDNEY INTERNATIONAL (2003)
The fatty acid transport function of fatty acid-binding proteins
J Storch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
分享论文
